ศูนย์วิจัยชีวโมเลกุลและเซลล์วิทยา

Publication

1. Sakkhachornphop S, Pichayangkul S, and Hirunpetcharat C. 2000.Production and purification of the 19- kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1₁₉) as a flag fusion protein expressed in Saccharomyces cerevisiae.Bull Chiang Mai Assoc Med Sci ;33 : 161-71.
2. Hirunpetcharat C, Sakkhachornphop S, Pichyangkul S, Krieg AM, and Good MF. Protective immunity induced in mice by parenteral immunization with yeast-expressed 19 kDa carboxyl terminal fragment   of   Plasmodium yoelii merozoite surface protein-1 (MSP1₁₉) using montanide 51, montanide 720 and CpG oligodeoxynucleotides as adjuvants. Presented at the 18^th Annual Health Sciences Meeting. June 8, 2000. Reserch Institute for Health Sciences. Chiang Mai University.
3. Chearwae W, Sakkhachornphop S, Chumpookhod A, Chumpookhod S, Palanan P, Tejafong K, Kitisri J, and Chanbancherd P. Application of dried blood spots in molecular epidemiological study of HIV-1. Presented at the 19^th Annual Health Sciences Meeting. August 24, 2001. Research Institute for Health Sciences. Chiang Mai University.
4. Hirunpetcharat C, Wipasa J, Sakkhachornphop S, Nitkumhan T, Zheng YZ, Pichyangkul S, Krieg AM, Walsh DS, Heppner DG, and Good MF. CpG oligonucleotide enhances immunity blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1 ₁₉) formulated in oil-based Montanides. Vaccine 2003; 21: 2923-32.
5. Tovanabutra S, Beyrer C, Sakkhachornphop S, et al. The Changing Molecular   Epidemiology of HIV-1 among Northern Thai Drug Users, 1999 to 2002. AIDS Res Hum Retroviruses 2004; 20 :Number 5 : Issuue date May 2004
6. Sakkhachornphop S, Tovanabutra S, Kijak G, et al. Development and Application of the Multi-region Subtype Specific PCR (MSSP) Assay for HIV-1 Subtypes B, C, CRF01_AE, Their Recombinant Forms, and Dual Infections. Oral presentation at the 13^th HIV Dynamics and Evolution. April 5-8, 2006.Marine Biology Labs. Woods Hole. USA.
7. Quan V.M., Celentano D.D., Rungruengthanakit K, Pasawad W, Vongchak T, Sakkhachornphop S, et al. Decline in CD4+ T lymphocyte count among substance abuse patients within one year after HIV-1 infection. Poster presentation at the XVI International AIDS Conference. August 13-18, 2006. Toronto. Canada.
8. Tovanabutra S, Kijak G, Beyrer C, Gammon-Richardson C, Sakkhachornphop S, et al. The link between multiple HIV-1 exposure and genetic complexity of strains is reinforced by identification of a second circulating recombinant form among injecting drug users in northern Thailand. Poster presentation at the XVI International AIDS Conference. August 13-18, 2006. Toronto. Canada.
9. Sakkhachornphop S, Tovanabutra S, Kijak G, et al. Screening for Circulating Recombinant Forms of HIV-1 among Northern Thai Drug Users with a Multi-region Subtype Specific PCR (MSSP) Assay. Poster presentation at the 5 ^th Joint Seminar on Biomedical Sciences. October 26-27, 2006. Kunming. China.

10. Tovanabutra S, Kijak G, Beyrer C, Gammon-Richardson C, Sakkhachornphop S, et al. Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand. AIDS Res Hum Retroviruses. 2007 Jun; 23(6):829-33.
11. Sakkhachornphop S, Tovanabutra S, Kijak G, et al. Development and Application of the Multi-region Subtype Specific PCR (MSSP) Assay for HIV-1 Subtypes B, C, CRF01_AE, Their Recombinant Forms, and Dual Infections. (in preparation)
12. Utaipat U, Ketkarn J, Sakkhachornphop S, et al. Duration of infection and low CD4:CD8 ratio correlate with CXCR4 utilization among HIV-1 subtype CRF01-AE. Poster presentation at the 4^th IAS Conference on HIV Pathogenesis, Treatment, and Prevention incorporating the 19 ^th ASHM Conference. July 22-25, 2007. Sydney. Australia.
13. Sakkhachornphop S, Tovanabutra S, Kijak G, et al. Development and Application of the Multi-region Subtype Specific PCR (MSSP) Assay for HIV-1 Subtypes B, C, CRF01_AE, Their Recombinant Forms, and Dual Infections. Oral presentation at the Fogarty International Clinical Research Scholars Program’s Scientific Session.  March 9 – 11, 2008. Marriott Bethesda and National Institutes of Health, Bethesda, MD, USA.
14. Sakkhachornphop S, Jiranusornkul, Kodchakorn K, Nangola S, Sirisanthana T, and Tayapiwatana C. Designed Zinc Finger Protein Interacting with the HIV-1 Integrase Recognition Sequence at 2-LTR-Circle Junctions. Protein Sci. 2009 Nov; 18(11):2219-30.
15. Sakkhachornphop S, Jiranusornkul, Kodchakorn K, Nangola S, Sirisanthana T, and Tayapiwatana C. Designed Zinc Finger Protein Interacting with the HIV-1 Integrase Recognition Sequence at 2-LTR-Circle Junctions. Poster presentation at the Fogarty International Clinical Research Scholars and Fellow and Doris Duke International Fellows Alumni Symposium. September 23 – 26, 2010. Bolger Center, Potomac, MD, USA.
16. Wipasa J, Okell L, Sakkhachornphop S, Suphavilai C, Chawansuntati K, Liewsaree W, Hafalla JC, Riley EM. Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity. PLoS Pathog. 2011 Feb 10; 7(2):e1001281.
17. Nangola S, Urvoas A, Valerio-Lepiniec M, Khamaikawin W, Sakkhachornphop S, Hong SS, Boulanger P, Minard P, Tayapiwatana C. Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein. Retrovirology. 2012 Feb 20;9:17. doi: 10.1186/1742-4690-9-17
18. Sakkhachornphop, S., Barbas III, C., Keawvichit, R., Wongworapat, K. and Tayapiwatana, C. (2012) Zinc Finger Protein Designed to Target 2-LTR Junctions Interferes with HIV Integration. Hum Gene Ther. 2012 Sep;23(9):932-42.